Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Acq. announced
Appointed director
Notes underwriting agrmnt
|
|
MedTech Acquisition Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Szela Mary T (CEO and President) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 172,500 options to buy
@ $11.51, valued at
$2M
|
|
| 08/14/2023 |
4
| Stevens Jennifer (Chief Regulatory Officer) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 08/14/2023 |
4
| Murphy Sean (CFO) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 62,500 options to buy
@ $12, valued at
$750k
|
|
| 08/14/2023 |
4
| Marshak Richard (Sr.VP, Corp. Dev. & Strategy) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 08/14/2023 |
4
| Katz Steven C (Chief Medical Officer) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 62,500 options to buy
@ $12, valued at
$750k
|
|
| 08/14/2023 |
4
| Cox Bryan F. (Chief Scientific & Manufact.) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 08/14/2023 |
4
| Wahlstrom Mats (10% Owner) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
4
| VON ESCHENBACH ANDREW C. (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
4
| Singhal Anil K. (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
4
| MATLIN DAVID J (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Acquired 931,904 shares
@ $0
Acquired 1,240,518 options to buy
@ $11.5, valued at
$14.3M
Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
Granted 100,000 preferred shares
@ $10, valued at
$1M
|
|
| 08/14/2023 |
4
| Martin George Kelly (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
4
| HICKS KERRY R (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 08/14/2023 |
4
| Desai Arjun JJ (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.34, valued at
$396.9k
|
|
| 12/28/2020 |
4
| MedTech Acquisition Sponsor LLC (10% Owner) has filed a Form 4 on MedTech Acquisition Corp|
Txns:
| Disposed of 75,000 options to buy
@ $0 |
|
| 12/28/2020 |
4
| MATLIN DAVID J (CFO) has filed a Form 4 on MedTech Acquisition Corp|
Txns:
| Disposed of 75,000 options to buy
@ $0 |
|
| 12/28/2020 |
4
| Dewey Christopher C (CEO) has filed a Form 4 on MedTech Acquisition Corp|
Txns:
| Disposed of 75,000 options to buy
@ $0 |
|
|
|